The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Differences in Physiologically Based Pharmacokinetic Predictions between Software Platforms Can Be Clinically Relevant: Cases of Levornestrogel and Ethinylestradiol Concentrations with SIMCYP versus PK-Sim from a User Perspective
Abstract
Background and objective Physiologically based pharmacokinetic models are increasingly applied in drug development and regulatory submissions. Differences in predictions between software platforms may challenge reproducibility and interpretation of results. We compared two widely used platforms, Simcyp and PK-Sim, using levonorgestrel and ethinylestradiol as model compounds, with parameters sourced from the literature, and implemented the simulations without data fitting. Methods Systematic reconstruction of drug, system, and virtual population models revealed structural and functional differences, including the number of compartments (12 in Simcyp versus 19 in PK-Sim), absorption model options, partition coefficient methods, and enzyme abundances. The clinical relevance of differences was also demonstrated in case of drug-drug interaction (DDI) assessment. Pharmacokinetic (PK) profiles were simulated and area under the curve (AUC) and peak plasma concentration (C max ) ratios computed for scenarios where ethinylestradiol and levonorgestrel were co-administrated with itraconazole and carbamazepine, the well-established inhibitor and inductor of cytochrome P450 (CYP)-mediated metabolism, respectively. Results Despite harmonized and consistent inputs, predicted pharmacokinetic metrics diverged and were clinically relevant. For levonorgestrel, Simcyp yielded higher C max (1.23 versus 0.59 ng/mL, C max ratio: 2.084) and AUC (10.79 versus 6.75 ng/mL/h, AUC ratio: 1.59), while ethi…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development
Jones, H., & Rowland‐Yeo, K. (2013) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.41 · Cited by 626
Population-Based Mechanistic Prediction of Oral Drug Absorption
Jamei, M., Turner, D., Yang, J., Neuhoff, S., Polak, S., Rostami-Hodjegan, A., & Tucker, G. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9099-y · Cited by 452
Willmann, S., Höhn, K., Edginton, A., Sevestre, M., Solodenko, J., Weiss, W., Lippert, J., & Schmitt, W. (2007) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-007-9053-5 · Cited by 250
Hanke, N., Frechen, S., Moj, D., Britz, H., Eissing, T., Wendl, T., & Lehr, T. (2018) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12343 · Cited by 169
Achour, B., Russell, M. R., Barber, J., & Rostami-Hodjegan, A. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.055632 · Cited by 168
Thelen, K., Coboeken, K., Willmann, S., Burghaus, R., Dressman, J. B., & Lippert, J. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22726 · Cited by 139
Luzon, E., Blake, K. V., Cole, S. M., Nordmark, A., Versantvoort, C. H. M., & Berglund, E. G. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.539 · Cited by 137
Hall, C., Lueshen, E., Mošat', A., & Linninger, A. A. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22811 · Cited by 109
Lippert, J., Burghaus, R., Edginton, A. N., Frechen, S., Karlsson, M. O., Kovar, A., Lehr, T., Milligan, P., Nock, V., Ramusovic, S., et al. (2019) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12473 · Cited by 108
Khalil, F., & Läer, S. (2014) · The AAPS Journal · doi:10.1208/s12248-013-9555-6 · Cited by 74
Research works printed but not linked: 1
- Agency EM. Qualification of novel methodologies for drug development: guidance to applicants. Amsterdam: European Medicines Agency; 2023.
Cited by
Fauziah, T. R., Kasinathan, G., Chew, T. K., et al. (2026) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-026-01016-y
Metadata
- Authors
- Massaux, C., Dogné, J.-M., & Musuamba, F. T.
- Affiliations
- University of Namur (BE)
- Corresponding author
- Musuamba, Flora Tshinanu
- Venue
- European Journal of Drug Metabolism and Pharmacokinetics
- Published
- 2026-04-04
- Volume
- 51
- Issue
- 3
- Pages
- 247-268
- ISSN
- 0378-7966 (ISSN-L)
- 2107-0180
- OpenAlex
- W7149631804
- Cited by
- 2
- References
- 22
- Citations by year
- 2026: 2
- FWCI
- 7.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- European Journal of Drug Metabolism and Pharmacokinetics (publishedVersion)
- PubMed (publishedVersion)
- Repository of the University of Namur (submittedVersion)
- Funders
- HORIZON EUROPE Framework Programme (GA 101137141)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Keywords
- physiologically based pharmacokinetic modeling, SimCYP, PK-Sim, levonorgestrel, ethinyl estradiol, drug-drug interactions, carbamazepine, itraconazole, cytochrome P450, model reproducibility, absorption modeling, partition coefficient, enzyme abundance, hormonal contraception
- MeSH terms
- Carbamazepine, Computer Simulation, Drug Interactions, Ethinyl Estradiol, Female, Humans, Models, Biological, Software, Reproducibility of Results, Levonorgestrel, Itraconazole, Area Under Curve
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differences in Physiologically Based Pharmacokinetic Predictions between Software Platforms Can Be Clinically Relevant: Cases of Levornestrogel and Ethinylestradiol Concentrations with SIMCYP versus PK-Sim from a User Perspective. https://app.cochat.ai/papers/10.1007/s13318-026-00988-1
- The paper
- Massaux, C., Dogné, J.-M., & Musuamba, F. T. (2026). Differences in Physiologically Based Pharmacokinetic Predictions between Software Platforms Can Be Clinically Relevant: Cases of Levornestrogel and Ethinylestradiol Concentrations with SIMCYP versus PK-Sim from a User Perspective. European Journal of Drug Metabolism and Pharmacokinetics. https://doi.org/10.1007/s13318-026-00988-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.